Cargando…

Enhanced Water Solubility and Oral Bioavailability of Paclitaxel Crystal Powders through an Innovative Antisolvent Precipitation Process: Antisolvent Crystallization Using Ionic Liquids as Solvent

Paclitaxel (PTX) is a poor water-soluble antineoplastic drug with significant antitumor activity. However, its low bioavailability is a major obstacle for its biomedical applications. Thus, this experiment is designed to prepare PTX crystal powders through an antisolvent precipitation process using...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qilei, Zu, Chang, Li, Wengang, Wu, Weiwei, Ge, Yunlong, Wang, Lingling, Wang, Li, Li, Yong, Zhao, Xiuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690586/
https://www.ncbi.nlm.nih.gov/pubmed/33105832
http://dx.doi.org/10.3390/pharmaceutics12111008
_version_ 1783614101669281792
author Yang, Qilei
Zu, Chang
Li, Wengang
Wu, Weiwei
Ge, Yunlong
Wang, Lingling
Wang, Li
Li, Yong
Zhao, Xiuhua
author_facet Yang, Qilei
Zu, Chang
Li, Wengang
Wu, Weiwei
Ge, Yunlong
Wang, Lingling
Wang, Li
Li, Yong
Zhao, Xiuhua
author_sort Yang, Qilei
collection PubMed
description Paclitaxel (PTX) is a poor water-soluble antineoplastic drug with significant antitumor activity. However, its low bioavailability is a major obstacle for its biomedical applications. Thus, this experiment is designed to prepare PTX crystal powders through an antisolvent precipitation process using 1-hexyl-3-methylimidazolium bromide (HMImBr) as solvent and water as an antisolvent. The factors influencing saturation solubility of PTX crystal powders in water in water were optimized using a single-factor design. The optimum conditions for the antisolvent precipitation process were as follows: 50 mg/mL concentration of the PTX solution, 25 °C temperature, and 1:7 solvent-to-antisolvent ratio. The PTX crystal powders were characterized via scanning electron microscopy, Fourier transform infrared spectroscopy, high-performance liquid chromatography–mass spectrometry, X-ray diffraction, differential scanning calorimetry, thermogravimetric analysis, Raman spectroscopy, solid-state nuclear magnetic resonance, and dissolution and oral bioavailability studies. Results showed that the chemical structure of PTX crystal powders were unchanged; however, precipitation of the crystalline structure changed. The dissolution test showed that the dissolution rate and solubility of PTX crystal powders were nearly 3.21-folds higher compared to raw PTX in water, and 1.27 times higher in artificial gastric juice. Meanwhile, the bioavailability of PTX crystal increased 10.88 times than raw PTX. These results suggested that PTX crystal powders might have potential value to become a new oral PTX formulation with high bioavailability.
format Online
Article
Text
id pubmed-7690586
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76905862020-11-27 Enhanced Water Solubility and Oral Bioavailability of Paclitaxel Crystal Powders through an Innovative Antisolvent Precipitation Process: Antisolvent Crystallization Using Ionic Liquids as Solvent Yang, Qilei Zu, Chang Li, Wengang Wu, Weiwei Ge, Yunlong Wang, Lingling Wang, Li Li, Yong Zhao, Xiuhua Pharmaceutics Article Paclitaxel (PTX) is a poor water-soluble antineoplastic drug with significant antitumor activity. However, its low bioavailability is a major obstacle for its biomedical applications. Thus, this experiment is designed to prepare PTX crystal powders through an antisolvent precipitation process using 1-hexyl-3-methylimidazolium bromide (HMImBr) as solvent and water as an antisolvent. The factors influencing saturation solubility of PTX crystal powders in water in water were optimized using a single-factor design. The optimum conditions for the antisolvent precipitation process were as follows: 50 mg/mL concentration of the PTX solution, 25 °C temperature, and 1:7 solvent-to-antisolvent ratio. The PTX crystal powders were characterized via scanning electron microscopy, Fourier transform infrared spectroscopy, high-performance liquid chromatography–mass spectrometry, X-ray diffraction, differential scanning calorimetry, thermogravimetric analysis, Raman spectroscopy, solid-state nuclear magnetic resonance, and dissolution and oral bioavailability studies. Results showed that the chemical structure of PTX crystal powders were unchanged; however, precipitation of the crystalline structure changed. The dissolution test showed that the dissolution rate and solubility of PTX crystal powders were nearly 3.21-folds higher compared to raw PTX in water, and 1.27 times higher in artificial gastric juice. Meanwhile, the bioavailability of PTX crystal increased 10.88 times than raw PTX. These results suggested that PTX crystal powders might have potential value to become a new oral PTX formulation with high bioavailability. MDPI 2020-10-22 /pmc/articles/PMC7690586/ /pubmed/33105832 http://dx.doi.org/10.3390/pharmaceutics12111008 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yang, Qilei
Zu, Chang
Li, Wengang
Wu, Weiwei
Ge, Yunlong
Wang, Lingling
Wang, Li
Li, Yong
Zhao, Xiuhua
Enhanced Water Solubility and Oral Bioavailability of Paclitaxel Crystal Powders through an Innovative Antisolvent Precipitation Process: Antisolvent Crystallization Using Ionic Liquids as Solvent
title Enhanced Water Solubility and Oral Bioavailability of Paclitaxel Crystal Powders through an Innovative Antisolvent Precipitation Process: Antisolvent Crystallization Using Ionic Liquids as Solvent
title_full Enhanced Water Solubility and Oral Bioavailability of Paclitaxel Crystal Powders through an Innovative Antisolvent Precipitation Process: Antisolvent Crystallization Using Ionic Liquids as Solvent
title_fullStr Enhanced Water Solubility and Oral Bioavailability of Paclitaxel Crystal Powders through an Innovative Antisolvent Precipitation Process: Antisolvent Crystallization Using Ionic Liquids as Solvent
title_full_unstemmed Enhanced Water Solubility and Oral Bioavailability of Paclitaxel Crystal Powders through an Innovative Antisolvent Precipitation Process: Antisolvent Crystallization Using Ionic Liquids as Solvent
title_short Enhanced Water Solubility and Oral Bioavailability of Paclitaxel Crystal Powders through an Innovative Antisolvent Precipitation Process: Antisolvent Crystallization Using Ionic Liquids as Solvent
title_sort enhanced water solubility and oral bioavailability of paclitaxel crystal powders through an innovative antisolvent precipitation process: antisolvent crystallization using ionic liquids as solvent
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690586/
https://www.ncbi.nlm.nih.gov/pubmed/33105832
http://dx.doi.org/10.3390/pharmaceutics12111008
work_keys_str_mv AT yangqilei enhancedwatersolubilityandoralbioavailabilityofpaclitaxelcrystalpowdersthroughaninnovativeantisolventprecipitationprocessantisolventcrystallizationusingionicliquidsassolvent
AT zuchang enhancedwatersolubilityandoralbioavailabilityofpaclitaxelcrystalpowdersthroughaninnovativeantisolventprecipitationprocessantisolventcrystallizationusingionicliquidsassolvent
AT liwengang enhancedwatersolubilityandoralbioavailabilityofpaclitaxelcrystalpowdersthroughaninnovativeantisolventprecipitationprocessantisolventcrystallizationusingionicliquidsassolvent
AT wuweiwei enhancedwatersolubilityandoralbioavailabilityofpaclitaxelcrystalpowdersthroughaninnovativeantisolventprecipitationprocessantisolventcrystallizationusingionicliquidsassolvent
AT geyunlong enhancedwatersolubilityandoralbioavailabilityofpaclitaxelcrystalpowdersthroughaninnovativeantisolventprecipitationprocessantisolventcrystallizationusingionicliquidsassolvent
AT wanglingling enhancedwatersolubilityandoralbioavailabilityofpaclitaxelcrystalpowdersthroughaninnovativeantisolventprecipitationprocessantisolventcrystallizationusingionicliquidsassolvent
AT wangli enhancedwatersolubilityandoralbioavailabilityofpaclitaxelcrystalpowdersthroughaninnovativeantisolventprecipitationprocessantisolventcrystallizationusingionicliquidsassolvent
AT liyong enhancedwatersolubilityandoralbioavailabilityofpaclitaxelcrystalpowdersthroughaninnovativeantisolventprecipitationprocessantisolventcrystallizationusingionicliquidsassolvent
AT zhaoxiuhua enhancedwatersolubilityandoralbioavailabilityofpaclitaxelcrystalpowdersthroughaninnovativeantisolventprecipitationprocessantisolventcrystallizationusingionicliquidsassolvent